SARA RYNSKI: Open Payments
NPI 1306564414 · OREGON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 29 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $538 · 2025 $957
Food & beverage: $957
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $354 |
| Sequel Med Tech, LLC | 2 | $190 |
| JAZZ PHARMACEUTICALS INC. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Novo Nordisk Inc | 3 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Exact Sciences Corporation | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: VRAYLAR, TWIIST, XYWAV, AIRSUPRA, GEMTESA, The Cologuard Plus Collection Kit, UBRELVY, TRELEGY ELLIPTA.
Industry payments across OH — which companies pay providers there.
